| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RWLK | Ordinary Shares, par value NIS 0.25 per share | Tax liability | -$929 | -1.06K | -5.8% | $0.88 | 17.2K | May 21, 2022 | Direct | F1, F2, F3 |
| holding | RWLK | Ordinary Shares, par value NIS 0.25 per share | 55.9K | May 21, 2022 | By Partnership | F3, F4 |
| Id | Content |
|---|---|
| F1 | Represents Ordinary Shares sold in the open market on May 21, 2022, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain restricted stock units previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan. This Form 4 is being filed late due to an administrative error. |
| F2 | Market price per share of ReWalk Robotics Ltd.'s (the "Company's") Ordinary Shares on the transaction date. |
| F3 | Prior to fiscal year 2020, the Reporting Person immediately and automatically assigned all Ordinary Shares underlying equity awards issued to the Reporting Person by the Company to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Ordinary Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Company with the permission of SCP. No Ordinary Shares were assigned to SCP by the Reporting Person after fiscal year 2019. This Form 4 reflects the Reporting Person's corrected direct and indirect beneficial ownership of Ordinary Shares as of May 21, 2022. |
| F4 | Based on filings made with the SEC, consists of 40,707 Ordinary Shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 Ordinary Shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 55,874 shares of the Company. |